Polivy 140 MG vials
Ended Awarded
- Contract number
- SPE2DB25FJZ56
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,046
Award facts
- Contract value 100% obligated
- $22,046.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,046.06 to AmerisourceBergen Drug Corp for the supply of Polivy 140 mg vials, with an ultimate completion date of October 9, 2025. This firm fixed-price contract, awarded on September 18, 2025, represents a non-competitive, non-set-aside delivery order issued against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor vehicle running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp fulfills diverse pharmaceutical supply requirements across the Defense Health Agency and other federal healthcare systems through its comprehensive DLA contract vehicle. Polivy (polatuzumab vedotin), a specialty oncology medication, falls within the company's extensive portfolio of brand-name and generic pharmaceuticals, specialty medications, and medical supplies that support military healthcare programs worldwide. This delivery order reflects routine procurement activity under the established pharmaceutical prime vendor program, enabling efficient sourcing of specialized therapeutics for defense medical supply chains.
Quick answers
Who was awarded contract SPE2DB25FJZ56?
SPE2DB25FJZ56 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FJZ56 worth?
The government has obligated $22,046 on SPE2DB25FJZ56.
Is contract SPE2DB25FJZ56 an order under another contract?
Yes. SPE2DB25FJZ56 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJZ56 competed?
The extent of competition for SPE2DB25FJZ56 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award